Reyes A M, Iriarte A, Martinez-Carrion M
Division of Molecular Biology and Biochemistry, School of Biological Sciences, University of Missouri, Kansas City 64110-2499.
J Biol Chem. 1993 Oct 25;268(30):22281-91.
The mitochondrial isozyme of aspartate aminotransferase (mAspAT), a dimeric pyridoxal phosphate (PLP)-dependent enzyme, is encoded by the nuclear genome and synthesized in the cytoplasm as a precursor protein (pmAspAT) containing a 29-residue amino-terminal signal peptide which is essential for its targeting and import into mitochondria. In the cytosolic-like environment of rabbit reticulocyte lysate, newly synthesized rat liver pmAspAT has been found to slowly fold and bind PLP (Mattingly, J. R., Jr., Youssef, J., Iriarte, A. and Martinez-Carrion, M. (1993) J. Biol. Chem. 268, 3925-3937). On the other hand, isolated mammalian (pig) mAspAT, when denatured with guanidine hydrochloride, seems unable to refold to a catalytically active state (West, S. M., and Price, N. C. (1990) Biochem. J. 265, 45-50). With the availability of rat liver recombinant precursor and mature forms of mAspAT as homogeneous, stable preparations, an assessment of the influence of the signal peptide on the in vitro refolding of this protein can be made. Following unfolding induced by guanidine hydrochloride, we have investigated the refolding process of this complex, dimeric coenzyme-dependent protein system by activity, fluorescence, and circular dichroism. Both mAspAT and pmAspAT can be efficiently renatured after rapid dilution of the denaturing agent at low protein concentrations. The equilibrium unfolding/refolding transitions and the kinetics of folding are protein concentration-independent and identical for both protein forms. Binding of coenzyme into the active site pocket seems to occur at a late step in the folding process of both mAspAT and pmAspAT, suggesting that in these proteins the coenzyme does not direct the folding of the polypeptide chain. These results indicate that the in vitro refolding of mAspAT is not regulated or influenced by the presence of the amino-terminal signal peptide. On the other hand, in vitro refolding in buffer is significantly faster than the folding of newly synthesized precursor protein in reticulocyte lysate examined in our previous report (reference above), pointing at the likely influence of cytosolic factors in modulating folding in the cell.
天冬氨酸氨基转移酶的线粒体同工酶(mAspAT)是一种依赖磷酸吡哆醛(PLP)的二聚体酶,由核基因组编码,在细胞质中以前体蛋白(pmAspAT)的形式合成,该前体蛋白含有一个29个残基的氨基末端信号肽,这对其靶向和导入线粒体至关重要。在兔网织红细胞裂解液的类似胞质溶胶的环境中,已发现新合成的大鼠肝脏pmAspAT会缓慢折叠并结合PLP(小马丁利,J.R.,优素福,J.,伊里亚尔特,A.和马丁内斯 - 卡里翁,M.(1993年)《生物化学杂志》268,3925 - 3937)。另一方面,分离的哺乳动物(猪)mAspAT在用盐酸胍变性时,似乎无法重新折叠成催化活性状态(韦斯特,S.M.和普赖斯,N.C.(1990年)《生物化学杂志》265,45 - 50)。有了大鼠肝脏重组前体和成熟形式的mAspAT作为均一、稳定的制剂,就可以评估信号肽对该蛋白体外重折叠的影响。在盐酸胍诱导的去折叠之后,我们通过活性、荧光和圆二色性研究了这个复杂的、二聚体的依赖辅酶的蛋白系统的重折叠过程。在低蛋白浓度下快速稀释变性剂后,mAspAT和pmAspAT都能有效地复性。平衡去折叠/重折叠转变以及折叠动力学与蛋白浓度无关,并且两种蛋白形式相同。辅酶结合到活性位点口袋似乎发生在mAspAT和pmAspAT折叠过程的后期,这表明在这些蛋白中辅酶并不指导多肽链的折叠。这些结果表明,mAspAT的体外重折叠不受氨基末端信号肽的存在调控或影响。另一方面,在缓冲液中的体外重折叠明显快于我们之前报告(上述参考文献)中检测的网织红细胞裂解液中新合成的前体蛋白的折叠,这表明胞质溶胶因子可能在调节细胞内的折叠中发挥作用。